Cardiovascular risk assessment and hyperlipidemia.
This article reviews how to identify and risk-stratify patients at risk for developing coronary artery disease (CAD) or who already have CAD (or coronary risk equivalents), and how to manage their lipids. This discussion is directed toward nurses, nurse practitioners, and physician assistants, who can and should play a pivotal role in identifying these patients and assisting the supervising physicians in management.
Becker
Jerry
J
The Heart Group, 415 West Columbia Street, Evansville, IN 47710, USA. beckercrc@aol.com
D003327:Coronary Disease / Q000517:prevention & control*; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D006949:Hyperlipidemias / Q000175:diagnosis* / Q000628:therapy*; D000960:Hypolipidemic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D018570:Risk Assessment; D012737:Sex Factors; D016387:Women's Health
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents